These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3890107)

  • 1. History of RA27/3 rubella vaccine.
    Plotkin SA; Buser F
    Rev Infect Dis; 1985; 7 Suppl 1():S77-8. PubMed ID: 3890107
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.
    Plotkin SA; Farquhar JD; Ogra PL
    JAMA; 1973 Aug; 225(6):585-90. PubMed ID: 4740523
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of the passive hemagglutination test for antibody to rubella virus and the passive hemagglutination response after vaccination.
    Cremer NE; Hagens SJ; Cossen CK
    J Clin Microbiol; 1981 Jan; 13(1):226-7. PubMed ID: 7462415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ten year follow-up of the persistence of humoral antibody to rubella virus acquired by vaccination with the Japanese To-336 vaccine.
    Hoshino M; Oka Y; Deguchi M; Hirayama M; Kono R
    J Biol Stand; 1982 Jul; 10(3):213-9. PubMed ID: 7130200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Directed immunization of female employees in the health services and schools using live rubella vaccine strain RA 27/3 on the basis of a screening test with radial hemolysis].
    Strauss J; Mrázová M; Macátová I; Růzicka E
    Cesk Epidemiol Mikrobiol Imunol; 1987 Oct; 36(5):271-9. PubMed ID: 2959379
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Wistar RA27/3 rubella virus vaccine in children.
    Balfour HH; Balfour CL; Edelman CK; Rierson PA
    Am J Dis Child; 1976 Oct; 130(10):1089-91. PubMed ID: 973611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella vaccines and the immunity gap.
    Andre FE; Florent G; du Pan RM
    Lancet; 1979 Aug; 2(8139):417-8. PubMed ID: 89471
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of antibody after subcutaneous vaccination with Wistar RA27/3 rubella vaccine.
    Hillary IB
    J Hyg (Lond); 1971 Sep; 69(3):369-72. PubMed ID: 5285940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR; Abramson JS; Harlan JE; Kelsey DS
    Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines to prevent rubella.
    André FE; Florent G; du Pan RM
    Lancet; 1980 Mar; 1(8169):657-8. PubMed ID: 6102664
    [No Abstract]   [Full Text] [Related]  

  • 15. The rubella story, 1881-1985.
    Horstmann DM
    S Afr Med J; 1986 Oct; Suppl():60-3. PubMed ID: 3535122
    [No Abstract]   [Full Text] [Related]  

  • 16. Current lessons from 20th century serosurveillance data on rubella.
    Cooper LZ
    Clin Infect Dis; 2001 Oct; 33(8):1287. PubMed ID: 11565066
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines].
    Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):12-4. PubMed ID: 3995568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inoculating properties of a rubella vaccine from the Orlov strains].
    Meshalova VN; Zhukova EA; Stepanov AN; Brusina EA
    Tr Inst Im Pastera; 1979; 53():112-7. PubMed ID: 400544
    [No Abstract]   [Full Text] [Related]  

  • 20. Rubella vaccine in the People's Republic of China.
    Han YR; Zhao K; Gong YX; Hao SL; Wang SZ; Wang CT
    Rev Infect Dis; 1985; 7 Suppl 1():S79. PubMed ID: 4001739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.